All
Expert Advises Genetic Profiling in MCL Can Be a Useful Tool in Treating The Disease
July 7th 2020“We learned from previous prospective studies (that) using chemoimmunotherapy for those patients with TP53 aberrations, the survival data compared with others that do not harbor this mutation are much less favorable,” said Dr. Jia Ruan.
Analysis Identifies Predictors of Survival in Older Patients With Mantle Cell Lymphoma
July 7th 2020“It is important to note that the data predates the widespread use of BTK inhibitors and even cellular therapies such as CAR T-cell therapy, specifically,” Dr. Reem Karmali said in an interview. “And so, it doesn't reliably reflect the potential advancements and survival that we've been able to achieve with these novel targeted therapies.”
The Importance of Integrating Community Health Workers into Traditional Practice
July 7th 2020“As people go through the process, it’s important that you don't minimize community health workers that are not certified because at the end of the day that paper doesn't create the bond,” says Rosalia Guerrero-Luera.
Focusing on Love, Kindness and Communication Can Improve Wellbeing in Patients With Cancer
July 3rd 2020“I think that when people are diagnosed with cancer, cancer really becomes their life,” Alessandra Tantawi said in a recent interview with CURE®. “And it's so hard to just have a ‘normal day’ where you can focus on anything besides cancer. And I think what's important is to spend time that is outside of the cancer treatment.”
CURE's Audience Honors and Recalls Fond Memories of Kathy LaTour
June 30th 2020“I had the honor of spending time with Kathy at CURE's inaugural Ovarian Cancer Heroes ceremony. She was such a nice, helpful person and did so much for the cancer survivor community,” one Facebook user wrote about CURE Magazine co-founder Kathy LaTour.
FDA Approves Keytruda as Initial Treatment for Advanced Colorectal Cancer with DNA Repair Defects
June 30th 2020Keytruda bested chemotherapy, delaying disease progression or death by 40%, in a clinical trial that led to the drug’s approval for use as a single initial treatment for patients with colorectal cancer.
ADT May Offer Some Protection From COVID-19 in Men with Prostate Cancer
June 30th 2020A PCF-funded study of men with prostate cancer in Italy suggests that men with prostate cancer who were taking ADT were 4 times less likely to be infected with the coronavirus than men who were not on ADT (androgen deprivation therapy), and 5 times less likely to die. These new findings are a game-changer and may lead to potential treatments for COVID-19, even in men without prostate cancer.
Survivors Tell Stories of Cancer and Coronavirus in 12th Annual Performance by Visible Ink
June 29th 2020In its first virtual performance, the Visible Ink writing therapy program at Memorial Sloan Kettering Cancer Center shared works by patients and staff members that touched on the COVID-19 pandemic and were interpreted by celebrity actors, singers and dancers.